Literature DB >> 22525354

Identification of gene pathways altered by deletion of the androgen receptor specifically in mineralizing osteoblasts and osteocytes in mice.

Patricia K Russell1, Michele V Clarke, Jarrod P Skinner, Tammy P S Pang, Jeffrey D Zajac, Rachel A Davey.   

Abstract

Androgens play a key role in skeletal growth and maintenance in males and can mediate their actions, at least in part, via the androgen receptor (AR) in osteoblasts. To investigate the mechanisms by which androgens exert their effects via the AR in mineralizing osteoblasts and osteocytes, we identified gene targets/pathways regulated by the AR using targeted gene expression and microarray approaches on bone isolated from mice in which the AR is specifically deleted in mineralizing osteoblasts and osteocytes (mOBL-ARKOs). Gene ontology mining indicated a number of biological processes to be affected in the bones of mOBL-ARKOs including skeletal and muscular system development and carbohydrate metabolism. All genes identified to have altered expression in the bones of mOBL-ARKOs were confirmed by Q-PCR for their androgen responsiveness in an androgen deprivation and replacement mouse model. The osteoblast genes Col1a1 and Bglap and the osteoclast genes Ctsk and RANKL (Tnfs11) were upregulated in the bones of mOBL-ARKOs, consistent with the increased matrix synthesis, mineralization, and bone resorption observed previously in these mice. Of significant interest, we identified genes involved in carbohydrate metabolism (adiponectin and Dpp4) and in growth and development (GH, Tgfb (Tgfb2), Wnt4) as potential targets of androgen action via the AR in mineralizing osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525354     DOI: 10.1530/JME-12-0014

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  8 in total

1.  The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes.

Authors:  Emily Jane Gallagher; Hui Sun; Caroline Kornhauser; Aviva Tobin-Hess; Sol Epstein; Shoshana Yakar; Derek LeRoith
Journal:  Diabetes Metab Res Rev       Date:  2014-03       Impact factor: 4.876

2.  Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells.

Authors:  M Victoria Recouvreux; J Boyang Wu; Allen C Gao; Svetlana Zonis; Vera Chesnokova; Neil Bhowmick; Leland W Chung; Shlomo Melmed
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

Review 3.  Sex steroid actions in male bone.

Authors:  Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

4.  Antioxidant response of osteoblasts to doxycycline in an inflammatory model induced by C-reactive protein and interleukin-6.

Authors:  A Tilakaratne; Mena Soory
Journal:  Infect Disord Drug Targets       Date:  2014

Review 5.  Human androgen deficiency: insights gained from androgen receptor knockout mouse models.

Authors:  Kesha Rana; Rachel A Davey; Jeffrey D Zajac
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

6.  TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model.

Authors:  Louie Semaan; Navneet Mander; Michael L Cher; Sreenivasa R Chinni
Journal:  BMC Cancer       Date:  2019-10-21       Impact factor: 4.430

7.  Testosterone delivered with a scaffold is as effective as bone morphologic protein-2 in promoting the repair of critical-size segmental defect of femoral bone in mice.

Authors:  Bi-Hua Cheng; Tien-Min G Chu; Chawnshang Chang; Hong-Yo Kang; Ko-En Huang
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

8.  SkeletalVis: an exploration and meta-analysis data portal of cross-species skeletal transcriptomics data.

Authors:  Jamie Soul; Tim E Hardingham; Ray P Boot-Handford; Jean-Marc Schwartz
Journal:  Bioinformatics       Date:  2019-07-01       Impact factor: 6.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.